Heterogeneity in the magnitude of the insulin gene effect on HLA risk in type 1 diabetes

Diabetes

Volumn 53, Issue 12, 2004, Pages 3286-3291

  Motzo, Costantino ^a   Contu, Daniela ^a   Cordell, Heather J ^b   Lampis, Rosanna ^a   Congia, Mauro ^a   Marrosu, Maria Giovanna ^a   Todd, John A ^b   Devoto, Marcella ^c,d   Cucca, Francesco ^a,e  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; DQB1 GENE; DRB1 GENE; GENE; GENE INTERACTION; GENE LOCUS; GENETIC HETEROGENEITY; GENOTYPE; HIGH RISK PATIENT; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN GENE; ITALY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; REGULATORY MECHANISM; RISK ASSESSMENT; SCHOOL CHILD; UNCERTAINTY;

DIABETES MELLITUS, TYPE 1; FAMILY; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS;

EID: 9444255760     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.12.3286     Document Type: Article

References (49)

1. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P: Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 69:820-830, 2001
2. Nerup J, Pociot F: A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet 69:1301-1313, 2001
3. Herr M, Dudbridge F, Zavattari P, Cucca F, Guja C, March R, Campbell RD, Barnett AH, Bain SC, Todd JA, Koeleman BP: Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. Hum Mol Genet 9:1291-1301, 2000
4. Zavattari P, Lampis R, Mulargia A, Loddo M, Angius E, Todd JA, Cucca F: Confirmation of the DRB1-DQB1 loci as the major component of IDDM1 in the isolated founder population of Sardinia. Hum Mol Genet 9:2967-2972, 2000
5. Erlich HA, Rotter JI, Chang JD, Shaw SJ, Raffel LJ, Klitz W, Bugawan TL, Zeidler A: Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes 45:610-614, 1996
6. Noble AJ, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA: The role of HLA classs II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 59:1134-1148, 1996
7. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G, Dahl-Jorgensen K, Ronningen KS, Thorsby E, Undlien DE: The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 64:793-800, 1999
8. Cucca F, Dudbridge F, Loddo M, Mulargia AP, Lampis R, Angius E, De Virgiliis S, Koeleman BP, Bain SC, Barnett AH, Gilchrist F, Cordell H, Welsh K, Todd JA: The HLA-DPB1-associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1. Diabetes 50:1200-1205, 2001
9. Zavattari P, Lampis R, Motzo C, Loddo M, Mulargia A, Whalen M, Maioli M, Angius E, Todd JA, Cucca F: Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum Mol Genet 10:881-889, 2001
10. Julier C, Hyer RN, Davies J, Merlin F, Soularu P, Briant L, Cathelineau G, Deschamps I, Rotter JI, Froguel P, Boitard C, Bell JI, Lathrop GM: Insulin-IGF2 region on chromosome lip encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 354:155-159, 1991
11. Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D, Concannon P, Gharani N, McCarthy MI, Olavasen MG, McCormack R, Guja C, Ionescu-Tirgoviste C, Undlien D, Ronningen K, Gillespie KM, Tuomilehto-Wolf E, Tuomilehto J, Bennett ST, Clayton D, Cordell H, Todd JA: Remapping the insulin gene/IDDM2 locus in type1 diabetes. Diabetes 53:1884-1889, 2004
12. Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD: The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293-297, 1997
13. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289-292, 1997
14. Chentoufi AA, Polychronakos C: Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51:1383-1390, 2002
15. Chentoufi AA, Palumbo M, Polychronakos C: Proinsulin expression by Hassall's corpuscles in the mouse thymus. Diabetes 53:354-359, 2004
16. Consortium TF-GA: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains: the Finnish-German APECED Consortium: Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 17:399-403, 1997
17. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D: Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395-1401, 2002
18. Kennedy C, German M, Rutter W: The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 9:293-298, 1995
19. Todd JA, Bell JI, McDevitt HO: HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1987
20. Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA: A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10:2025-2037, 2001
21. Nepom BS, Nepom GT, Coleman M, Kwok WW: Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc Natl Acad Sci USA 93:7202-7206, 1996
22. Wen L, Wong FS, Tang J, Chen NY, Altieri M, David C, Flavell R, Sherwin R: In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med 191:97-104, 2000
23. Schmidt D, Verdaguer J, Averill N, Santamaria P: A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 186:1059-1075, 1997
24. Serreze DV, Holl TM, Marron MP, Graser RT, Johnson EA, Choisy-Rossi C, Slattery RM, Lieberman SM, DiLorenzo TP: MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. J Immunol 172:871-879, 2004
25. Morgan DJ, Nugent CT, Raveney BJ, Sherman LA: In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells. J Immunol 172:1000-1008, 2004
26. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N: Positional cloning of the APECED gene. Nat Genet 17:393-398, 1997
27. Bain SC, Prins JB, Hearne CM, Rodrigues NR, Rowe BR, Pritchard LE, Ritchie RJ, Hall JR, Undlien DE, Ronningen KS: Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat Genet 2:212-215, 1992
28. Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E: IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46:712-720, 2003
29. van der Auwera B, Schuit F, Lyaruu I, Falorni A, Svanholm S, Vandewalle CL, Gorus FK: Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry. J Clin Endocrinol Metab 80:2567-2573, 1995
30. Metcalfe KA, Hitman GA, Fennessy MJ, McCarthy MI, Tuomilehto J, Tuomilehto-Wolf E: In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk: DiMe (Childhood Diabetes in Finland) Study Group. Diabetologia 38:1223-1229, 1995
31. Laine AP, Hermann R, Knip M, Simell O, Akerblom HK, Ilonen J: The human leukocyte antigen genotype has a modest effect on the insulin gene polymorphism-associated susceptibility to type 1 diabetes in the Finnish population. Tissue Antigens 63:72-74, 2004
32. Cordell HJ, Todd JA, Bennett ST, Kawaguchi Y, Farral M: Two locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type I diabetes. Am J Hum Genet 57:920-934, 1995
33. Dizier MH, Babron MC, Clerget-Darpoux F: Interactive effect of two candidate genes in a disease: extension of the marker-association-segregation chi(2) method. Am J Hum Genet 55:1042-1049, 1994
34. She JX, Bui MM, Tian XH, Muir A, Wakeland EK, Zorovich B, Zhang LP, Liu MC, Thomson G, Maclaren NK: Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity 18:195-203, 1994
35. Cordell HJ, Wedig GC, Jacobs KB, Elston RC: Multilocus linkage tests based on affected relative pairs. Am J Hum Genet 66:1273-1286, 2000
36. Lampis R, Morelli L, Congia M, Macis MD, Mulargia A, Loddo M, De Virgiliis S, Marrosu MG, Todd JA, Cucca F: The inter-regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet 9:2959-2965, 2000
37. Bugawan TL, Erlich HA: Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 33:163-170, 1991
38. Cucca F, Frau F, Lampis R, Floris M, Argiolas L, Macis D, Cao A, De Virgiliis S, Congia M: HLA-DQB1*0305 and -DQB1*0304 alleles among Sardinians: evolutionary and practical implications for oligotyping. Hum Immunol 40:143-149, 1994
39. Horn GT, Bugawan TL, Long CM, Erlich HA: Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci USA 85:6012-6016, 1988
40. Wordsworth BP, Allsopp CE, Young RP, Bell JI: HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes. Immunogenetics 32:413-418, 1990
41. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA: Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 33:267-275, 1991
42. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F: Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisateffite locus. Nat Genet 9:284-292, 1995
43. Thomson G: Mapping disease genes: family-based association studies. Am J Hum Genet 57:487-498, 1995
44. Frongia O, Mastinu F, Sechi GM: Prevalence and 4-year incidence of insulin-dependent diabetes mellitus in the province of Oristano (Sardinia, Italy). Acta Diabetol 34:199-205, 1997
45. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516, 1993
46. Risch N: Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241, 1990
47. Cordell HJ, Todd JA, Hill NJ, Lord CJ, Lyons PA, Peterson LB, Wicker LS, Clayton DG: Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes. Genetics 158:357-367, 2001
48. Cordell HJ: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 11:2463-2468, 2002
49. Clayton D, McKeigue PM: Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358:1356-1360, 2001